Jennison Associates’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-58,139
Closed -$1.36M 626
2021
Q4
$1.36M Sell
58,139
-19,501
-25% -$455K ﹤0.01% 579
2021
Q3
$1.29M Buy
+77,640
New +$1.29M ﹤0.01% 581
2021
Q1
Sell
-580,567
Closed -$31M 660
2020
Q4
$31M Buy
580,567
+428,136
+281% +$22.9M 0.02% 289
2020
Q3
$6.29M Buy
152,431
+608
+0.4% +$25.1K 0.01% 416
2020
Q2
$7.36M Sell
151,823
-15,404
-9% -$747K 0.01% 403
2020
Q1
$7.07M Buy
167,227
+17,642
+12% +$745K 0.01% 368
2019
Q4
$6.4M Buy
+149,585
New +$6.4M 0.01% 414
2017
Q1
Sell
-1,372,679
Closed -$39.6M 632
2016
Q4
$39.6M Buy
+1,372,679
New +$39.6M 0.04% 304
2016
Q2
Sell
-58,417
Closed -$1.63M 619
2016
Q1
$1.63M Sell
58,417
-534,789
-90% -$14.9M ﹤0.01% 534
2015
Q4
$21.1M Sell
593,206
-504,158
-46% -$18M 0.02% 416
2015
Q3
$36.3M Sell
1,097,364
-1,423,960
-56% -$47.1M 0.04% 351
2015
Q2
$106M Buy
2,521,324
+40,103
+2% +$1.68M 0.1% 194
2015
Q1
$80.9M Sell
2,481,221
-392,795
-14% -$12.8M 0.07% 245
2014
Q4
$91.3M Sell
2,874,016
-29,473
-1% -$936K 0.09% 223
2014
Q3
$71.9M Sell
2,903,489
-150,036
-5% -$3.71M 0.07% 257
2014
Q2
$69M Buy
3,053,525
+4,108
+0.1% +$92.8K 0.06% 273
2014
Q1
$74.2M Buy
3,049,417
+1,485,866
+95% +$36.2M 0.07% 252
2013
Q4
$39.1M Buy
1,563,551
+50,359
+3% +$1.26M 0.04% 356
2013
Q3
$41.6M Sell
1,513,192
-9,822
-0.6% -$270K 0.04% 331
2013
Q2
$27.6M Buy
+1,523,014
New +$27.6M 0.03% 386